[1]谷欣,刘敏,桑云华,等.通腑饮对腹腔高压症大鼠血乳酸、肠黏膜通透性和近期预后的影响[J].西部中医药,2019,32(08):5-8.
 GU Xin,LIU Min,SANG Yunhua,et al.Effects of Tongfu Drink on Short-term Prognosis, Intestinal Mucosal Permeability and Lactic Acid in the Blood of the Rats with Abdominal Hypertension[J].Western Journal of Traditional Chinese Medicine,2019,32(08):5-8.
点击复制

通腑饮对腹腔高压症大鼠血乳酸、肠黏膜通透性和近期预后的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年08期
页码:
5-8
栏目:
出版日期:
2019-08-15

文章信息/Info

Title:
Effects of Tongfu Drink on Short-term Prognosis, Intestinal Mucosal Permeability and Lactic Acid in the Blood of the Rats with Abdominal Hypertension
文章编号:
1004-6852(2019)08-0005-04
作者:
谷欣刘敏桑云华龙宏杰
广州医科大学附属惠州医院,广州 惠州 516000
Author(s):
GU Xin, LIU Min, SANG Yunhua, LONG Hongjie
Huizhou Hospital Affiliated to Guangzhou Medical University, Huizhou 516000, China;
关键词:
通腑饮大鼠腹腔高压症乳酸近期预后肠黏膜通透性关系
Keywords:
Tongfu drink rats abdominal hypertension lactic acid short-term prognosis intestinal mucosal permeability correlation
分类号:
R932
文献标志码:
A
摘要:
目的:探讨通腑饮对腹腔高压症大鼠的血乳酸、肠黏膜通透性和近期预后的影响及其相互关系。方法:将40只健康成年雄性SD大鼠随机分为A组和B组,每组20只。2组均通过向腹腔内注入氮气,建立腹腔高压症模型,2组均维持腹内压20 mm Hg,持续48小时,A组采用通腑饮方煎制成药液灌肠,每次5 mL,1次/6 h,共8次,B组同期采用等量生理盐水灌肠治疗。检测比较2组治疗前后的血乳酸水平,并统计2组大鼠48小时死亡率。48小时后采用EB和FITC-dextran方法检测2组小肠黏膜通透性。比较2组不同预后大鼠治疗前后的血乳酸水平和小肠黏膜通透性,分析腹腔高压症大鼠血乳酸水平和小肠黏膜通透性与48小时死亡率的关系。结果:与治疗前比较,A组治疗12小时、24小时及48小时的血乳酸水平均降低,B组治疗12、24及48小时的血乳酸水平则升高,且A组治疗12小时、24小时及48小时的血乳酸水平均低于B组(P<0.05)。A组48小时死亡率为10.00%(2/20),B组48小时死亡率为40.00%(8/20),A组48小时死亡率低于B组(P<0.05)。且2组存活大鼠治疗前后的血乳酸水平以及小肠黏膜通透性均低于其死亡大鼠(P<0.05)。Spearman分析结果显示,大鼠腹腔高压症血乳酸水平和小肠黏膜通透性与其48小时死亡率均密切相关。结论:通腑饮治疗腹腔高压症大鼠有助于降低其血乳酸、肠黏膜通透性并改善其预后,且大鼠血乳酸、肠黏膜通透性与近期预后均密切相关,可作为其近期预后评估的参考指标。
Abstract:
Objective: To discuss the effects of Tongfu drink on lactic acid, intestinal mucosal permeability and short-term prognosis of the rats with abdominal hypertension and their correlation. Methods: Forty healthy adult male SD rats were randomized into group A (n=20) and group B (n=20). The rats with abdominal hypertension were prepared by injecting nitrogen into abdomen in both groups, and maintaining intra-abdominal pressure at 20 mmHg, for 48 hours continuously, group A accepted the enema of herbal decoction using Tongfu drink, 5 mL each time, once every six hours, altogether eight times, group B received the enema of equivalent physiological saline in the corresponding period. To detect and compare the levels of serum lactic acid before and after treating between both groups, and count mortality rate within 48 hours in both groups. EB and FZTC-dextran method were used to measure intestinal mucosal permeability in 48 hours. To compare the levels of serum lactic acid and intestinal mucosal permeability before and after treating of the rats in both groups, and analyze the correlation between the levels of serum lactic acid and intestinal mucosal permeability of the rats with abdominal hypertension and mortality rate within 48 hours. Results: Compared with before treating, the levels of lactic acid of group A reduced in 12, 24 and 48 hours after treating, while the levels of lactic acid of group B raised in 12, 24 and 48 hours after treating, and the levels of serum lactic acid of group A in 12, 24 and 48 hours after treating were lower than these of group B (P<0.05). 48-hour mortality of group A was 10.00% (2/20), lower than 40.00% of group B (8/20) (P<0.05). The levels of lactic acid and intestinal mucosal permeability of survival rats in both groups were lower than these of the dead (P<0.05). The results of Spearman analysis showed that the levels of serum lactic acid and intestinal mucosal permeability were closely related to 48-hour mortality. Conclusion: Tongfu drink in the treatment for the rats with abdominal hypertension is helpful to lower the levels of lactic acid and intestinal mucosal permeability, and improve the prognosis, the levels of lactic acid and intestinal mucosal permeability are closely related to short-term prognosis, which could be taken as the reference indexes for the evaluation of short-term prognosis.

相似文献/References:

[1]覃仕化,汪悦.痹痛灵颗粒对胶原诱导性关节炎大鼠血清及滑膜组织匀浆中IL-2的影响[J].西部中医药,2011,24(11):9.
[2]陈进凡,刘媛,柳渊洁,等.肠毒清口服液对全身炎症反应综合征大鼠体质量及进食量的影响[J].西部中医药,2011,24(11):10.
[3]寇宁,张玉香,王一强,等.温肾胶囊对抑郁大鼠模型性功能的影响[J].西部中医药,2013,26(05):12.
 KOU Ning,ZHANG Yuxiang,WANG Yiqiang,et al.Effects of W enShen Capsule on Sexual Function of Depressed Rat Model[J].Western Journal of Traditional Chinese Medicine,2013,26(08):12.
[4]董敏,瞿东晖,杨雪萍,等.产益康栓对大鼠阴道黏膜刺激及过敏反应的实验研究[J].西部中医药,2013,26(03):19.
 DONG Min,QU Donghui,YANG Xueping,et al.Experimental Study of the Effects of ChanY iKang Suppository on the Irritation and Allergy of Vaginal Mucosa in Rats[J].Western Journal of Traditional Chinese Medicine,2013,26(08):19.
[5]吴丽萍,李玉霞,尚菁,等.知柏地黄丸对性早熟模型大鼠FSH、T水平的影响*[J].西部中医药,2013,26(11):10.
 WU Liping,LI Yuxia,SHANG Jing,et al.Action of ZhiBai DiHuang Pill on the Levels of FSH and T of Rats with Sexual Precocity[J].Western Journal of Traditional Chinese Medicine,2013,26(08):10.
[6]赵萍.消肿止痛合剂对大鼠骨折愈合中VEGF表达的影响[J].西部中医药,2013,26(11):16.
 ZHAO Ping.Effects of XiaoZhong ZhiTong Mixture on VEGF Expressions of Rats in the Healing Course of Bone Fracture[J].Western Journal of Traditional Chinese Medicine,2013,26(08):16.
[7]高晓兰,朱增强,陈彦文,等.当归补血汤加味对血管性痴呆大鼠的脑保护作用研究[J].西部中医药,2013,26(04):22.
 GAO Xiaolan,ZHU Zengqiang,CHEN Yanwen,et al.Study on Modified DangGui BuXueTang to Cerebral Protection of Rats with Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2013,26(08):22.
[8]柳文红,张博,王思农△.藏药十八味欧曲膏对慢性湿疹模型大鼠INF-γ的影响*[J].西部中医药,2013,26(11):66.
 LIU Wenhong,ZHANG Bo,WANG Sinong.Effects of Tibetan Drug ShiBaWei OuQu Ointment on INF-γ of Rat Model with Chronic Eczema[J].Western Journal of Traditional Chinese Medicine,2013,26(08):66.
[9]贡布东智,阿召,何强,等.藏药“五味麝香丸”药效学实验研究[J].西部中医药,2013,26(08):55.
 GONGBU Dongzhi,A Zhao,HE Qiang,et al.Experimental Study on the Pharmacodynamics of Tibetan Drug “WuWei SheXiang Pill"[J].Western Journal of Traditional Chinese Medicine,2013,26(08):55.
[10]王玉珠,王曌滢.止痒油膏外敷止痒作用的实验研究*[J].西部中医药,2013,26(12):15.
 WANG Yuzhu,WANG Zhaoying.Experimental Study on Relieving Itching of ZhiYang Ointment for External Use[J].Western Journal of Traditional Chinese Medicine,2013,26(08):15.

备注/Memo

备注/Memo:
收稿日期:2018-01-01*基金项目:广东省2016年建设中医药强省科研立项资助课题(编号20161253)。作者简介:谷欣(1980—),男,副主任医师。研究方向:重症医学。
更新日期/Last Update: 2019-08-15